We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Akebia Announces Successful Completion of Single Ascending Dose Phase 2a Pilot Study of AKB-6548 for Anemia

Product News   May 04, 2011

 
Akebia Announces Successful Completion of Single Ascending Dose Phase 2a Pilot Study of AKB-6548 for Anemia
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

CEPI Expands Global Footprint of Its COVID- 19 Vaccine Lab Network

Product News

The Coalition for Epidemic Preparedness Innovations, or CEPI, will expand its centralized laboratory network, a global initiative to harmonize the assessment of COVID-19 vaccine candidates undergoing testing, to also evaluate clinical trial samples against priority Variants of Concern.

READ MORE

FDA Approves Orgenesis IDE for Pilot Clinical Trial of its Tissue Genesis Icellator2(R)

Product News

Orgenesis Inc. announces it has been granted Investigational Device Exemption (IDE) approval by the United States Food and Drug Administration (FDA) to conduct a first-in-human feasibility study of the Tissue Genesis Icellator2(R) to treat Acute Respiratory Distress Syndrome (ARDS) resulting from COVID-19 infection.

READ MORE

Cytel Appoints New VP Scientific Strategy & Innovation To Further Drive Bayesian Innovation

Product News

Cytel Inc. is pleased to announce that renowned Bayesian clinical trial design specialist Dr Kyle Wathen has joined Cytel as Vice President of Scientific Strategy and Innovation.

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE